Comprehensive pharmacological geriatric assessment compared to usual care in an older adult with cancer in the absence of polypharmacy
- 18 June 2023
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 29 (7) , 1776-1780
Abstract
Introduction: Medication reconciliation as part of a Comprehensive Geriatric Assessment by a specialist pharmacist is a process that has been shown to be beneficial in terms of medication adherence in patients taking oral anticancer medication and potentially cost-effective in cancer patients. Medication review guidelines in older adults with cancer suggest using polypharmacy (≥ 5 medications) as an indication for medication review in older adults with cancer. Case report: We present a case where a medication review as part of a Comprehensive Geriatric Assessment in the absence of polypharmacy resulted in two pharmacist interventions when standard care resulted in no intervention. A 71-year-old male prescribed capecitabine for rectal cancer had a medication reconciliation done as standard care before starting an oral anticancer medication. He then proceeded to get a medication review as part of a Comprehensive Geriatric Assessment and was deemed to have a potentially excessive anticholinergic burden and underprescribed gastro protection. This case is interesting as it occurred in a patient who would not have met the current inclusion criteria for a medication review as part of a Comprehensive Geriatric Assessment. Management and outcome: As a result of the Comprehensive Geriatric Assessment, a letter was written to the patient's general practitioner, recommending a change to anti-depressant therapy to optimise anticholinergic burden, as well as introducing a proton-pump inhibitor upon completion of the Capecitabine protocol concurrent with radiotherapy, to confer gastro-protection against the antidepressant medication, as per the START criteria. Upon discharge from medical oncology, neither of the changes had been adopted by the patient's general practitioner. This highlights one of the challenges facing clinical pharmacists in an outpatient setting, where evidence-based recommendations are not always implemented as care transitions from tertiary to primary care. Conclusion: Comprehensive Geriatric Assessment is a process that identifies potential issues in older adults with cancer that aren’t identified with standard medication review. This is also evident for medication reviews as part of a Comprehensive Geriatric Assessment, and where resources allow, and recommendations are likely to be accepted, it should be offered to all older adults with cancer. Pharmacists are still faced with challenges in implementing recommendations from medication reviews, particularly in healthcare systems where pharmacist prescribing has yet to be introduced.Keywords
This publication has 17 references indexed in Scilit:
- Systematic Review and Meta-Analysis on the Associations of Polypharmacy and Potentially Inappropriate Medication With Adverse Outcomes in Older Cancer PatientsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2020
- Integrated geriatric assessment and treatment (INTEGERATE) in older people with cancer planned for systemic anticancer therapy.Journal of Clinical Oncology, 2020
- MEDICATION RECONCILIATION AND REVIEW TO PREVENT MEDICATION ERRORS IN ELDERLY CANCER PATIENTSJournal of Geriatric Oncology, 2019
- Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-AnalysisThe Oncologist, 2019
- Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and PreventabilityThe Oncologist, 2019
- STOPP/START criteria for potentially inappropriate prescribing in older people: version 2Age and Ageing, 2014
- Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project.Journal of Clinical Oncology, 2011
- Pharmacokinetics and drug metabolism in the elderlyDrug Metabolism Reviews, 2009
- Toxicity and response criteria of the Eastern Cooperative Oncology GroupAmerican Journal of Clinical Oncology, 1982
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976